📰 Third Harmonic Bio News
Page 3 - Third Harmonic Bio News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Third Harmonic Bio. Real-time updates on events, politics, business and more.
July 25, 2023
Shares of Third Harmonic Bio, Inc. (THRD) climbs 17% on Tuesday after the company announced its next-generation product candidate, THB335, for the treatment of mast cell-mediated inflammatory diseases.
June 9, 2023
Given the difficult market conditions over the past year, it’s not surprising that several of the most prominent IPOs over the past 12 months, including Third Harmonic Bio, Inc.
May 11, 2023
Company Progresses Preclinical Next-Generation oral KIT Inhibitor for Mast Cell-Mediated Inflammatory DiseasesSAN FRANCISCO, May 11, 2023 -- Third Harmonic Bio, Inc. , a biopharmaceutical company... | May 11, 2023
March 29, 2023
Company Progresses Preclinical Next-Generation oral KIT Inhibitor for Mast Cell-Mediated Inflammatory DiseasesSAN FRANCISCO, March 29, 2023 -- Third Harmonic Bio, Inc. , a biopharmaceutical company... | March 29, 2023
December 16, 2022
The Biden administration revives free at-home COVID-19 tests; CDC releases new BMI charts for children with severe obesity.
October 20, 2022
Prime Medicine has yet to test prime editing in humans, but the biotech company garnered enough investor interest to boost the size of its IPO, raising $175 million. Prime claims its technology has key advantages over other gene-editing technologies and the IPO cash will support a pipeline that currently spans 18 programs.